Spots Global Cancer Trial Database for A Study of BMS-986207 Given Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of BMS-986207 Given Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid Tumors
Official Title: Phase 1/2a First-In-Human Study of BMS-986207 Monoclonal Antibody Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid Tumors
Study ID: NCT02913313
Conditions
Study Description
Brief Summary: The purpose of this study is to evaluate the safety and effectiveness of experimental medication BMS-986207 by itself, in combination with Nivolumab, and in combination with both nivolumab and ipilimumab in participants with solid cancers that are advanced or have spread.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution - 0001, Hackensack, New Jersey, United States
Local Institution - 0003, New York, New York, United States
Local Institution - 0012, Philadelphia, Pennsylvania, United States
Local Institution - 0002, Philadelphia, Pennsylvania, United States
Local Institution - 0009, Pittsburgh, Pennsylvania, United States
Local Institution - 0010, Salt Lake City, Utah, United States
Local Institution - 0023, Caba, Ciudad Autónoma De Buenos Aires, Argentina
Local Institution - 0019, Córdoba, Cordoba, Argentina
Local Institution - 0022, Buenos Aires, Distrito Federal, Argentina
Local Institution - 0006, Nedlands, Western Australia, Australia
Local Institution - 0008, Ottawa, Ontario, Canada
Local Institution - 0007, Toronto, Ontario, Canada
Local Institution - 0021, Santiago, Metropolitana, Chile
Local Institution - 0004, Kashiwa-shi, Chiba, Japan
Local Institution - 0005, Chuo-ku, Tokyo, Japan
Local Institution - 0017, Bucharest, , Romania
Local Institution - 0016, Cluj, , Romania
Local Institution - 0018, Craiova, , Romania
Local Institution - 0015, Florești, , Romania
Local Institution - 0020, Singapore, , Singapore
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
